Recent advances and developments in the treatment of acute renal failure

Bibliography

• ANDERSON RJ, SCHRIER RW: Acute renal failure. In: Diseases of the Kidney and Urinary Tract. Schrier RW (Ed.), Lippincott Willima & Wilkins, Philadelphia (2001):1093–1136.
   Google Scholar
• CUMMINGS BS, SCHNELLMANN RG: Pathophysiology of nephrotoxic cell injury. In: Diseases of the Kidney and Urinary Tract. Schrier RW (Ed.), Lippincott Willima & Wilkins, Philadelphia (2001):1071–1091.
   Google Scholar
• EDELSTEIN CL, SCHRIER RW: Pathophysiology of Ischemic acute renal Injury. In: Diseases of the Kidney and Urinary Tract. Schrier RW (Ed.), Lippincott Willima & Wilkins, Philadelphia (2001):1041–1070.
   Google Scholar
• SHERIDAN AM, BONVENTRE J1/: Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Cum: Opin. Nephrol. Hypertension (2000) 9:427–434.
   Google Scholar
• HAMMERMAN MR, SAFERSTEIN R, HARRIS RC, TOBACK FG, HUMES HD: Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am. j Physiol. Rena] Physiol. (2000) 279:F3–11.
   Google Scholar
• UEDA N, KAUSHAL G, SHAH S: Apoptotic mechanisms in acute renal failure. Am. J. Med. (2000) 108:463–415.
   Web of Science ®Google Scholar
• RANA A, SATHYANARAYANA E LIEBERTHAL W: Role of apoptosis of renal tubular cells in acute renal failure: therapeutic implications. Apoptosis (2001) 6:83–102.
   PubMed Web of Science ®Google Scholar
• ORTIZ A, LARZ C, CATALON MP et al.: Expression of apoptosis regulatory proteins in tubular epithelium stress in culture or following acute renal failure. Kidney _Lai (2000) 57:969–981.
   PubMed Web of Science ®Google Scholar
• LEVINE JS, LIEBERTHAL W: Terminal pathways to cell death. Apoptosis (2001) 30–59.
   Google Scholar
• VENKATARAMAN R, KELLUM JA: Novel approaches to the treatment of acute renal failure. Expert Opin. Investig. Drugs (2000) 9(11):2579–2592.
   PubMed Web of Science ®Google Scholar
• ALLGREN RL, MARBURY TC, RAHMAN SN et al.: Anaritide in acute tubular necrosis. N Engl. j Med. (1997) 336:828.
   PubMed Web of Science ®Google Scholar
• KURNICK BR, ALLGREN RL, GENTER FC, SOLOMON RJ, BATES ER, WEISBERG LS: Prospective study of atrial natriuretic peptide for the prevention of radio contrast induced nephropathy. Am. Kidney Dis. (1998) 31:674–680.
   PubMed Web of Science ®Google Scholar
• HERBERT MK, GINZEL S, MUHLSEHLEGEL S, WEIS KH: Concomitnat treatment with urodilatin (ularitide) does not improve renal function in patients with acute renal failure after major abdominal surgery - a randomized controlled trial. Wein KIM. Wocherishr. (1999) 111:126–128.
   PubMed Web of Science ®Google Scholar
• MOLITORIS BA, WEINBERG JM, VENKATACHALAM MA, ZAGER RA, NATH KA, GOLIGORSKY MS: Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am. j Physiol Rena] Physiol. (2000) 278:F1–F12.
   Google Scholar
• WU C: Recent discovery and developmentof endothelin receptor antagonist. Expert Opin. Ther. Patents (2000) 10(11):1653–1668.
   Web of Science ®Google Scholar
• SAFERSTEIN R: Endothelin: the yin and yang of ischemic acute renal failure. Kidney Inter. (2001) 59:1590–1591.
   PubMed Web of Science ®Google Scholar
• MAREE J, HAWETSON TD, BECKER GJ, JONES CL: Simultaneous blockade of endothelin A and B receptors in ischemia is detrimental to long-term kidney function. Kid. Int. (2001) 59:1333–1341.
   PubMed Web of Science ®Google Scholar
• PFLUEGER A, LARSON TS, NATH KA, GROSS JM, KNOX FG: Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc. (2000) 75:1275–1283.
   PubMed Web of Science ®Google Scholar
• OKUSA MD, LINDEN J, HUANG L, ROSIN DL, SMITH DF, SULLIVAN G: Enhanced protection from renal ischemia-reperfusion injury with A(2A) -adenosine receptor activation and PDE 4 inhibition. Kidney Int. (2001) 59:2114–2125.
   PubMed Web of Science ®Google Scholar
• GALINDO A, VARGAS ML, GARCIA ESTAN J, FUENTES T, HERNANDEZ J: Synergistic interaction of diazepam with 3', 5'-cyclic adenosine monophosphate - elevating agents on rat aortic rings. Eur. Pharmaco] (2001) 428:269–275.
   PubMed Web of Science ®Google Scholar
• NAKAMOTO M, SHAPIRO JI, SHANLEY PF, CHAN L, SCHRIER RW: In vitro and in vivo protective effect of antriopeptin III on ischemic acute renal failure. j Clin Invest. (1987) 80:698–705.
   PubMed Web of Science ®Google Scholar
• CONGER JD, FALK SA, YUAN B, SCHRIER RW: Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int. (1989) 35:1126–1132.
   PubMed Web of Science ®Google Scholar
• AKABANE S, IMANISHI N, MATSUSHIMA Y: Renal actions of atrial natriuretic peptide on the post-ischemic kidney. Can. I Physiol Pharmacol (1988) 66:601–607.
   PubMed Web of Science ®Google Scholar
• SCHAFFERIIANS K, HEIDBREDER E, SPERBER S, DAMMRICH J, HEIDLAND A: Atrial natriuretic peptide in gentamicin-induced changes in renal blood flow. Kidney Int. (1989) 344:13–19.
   Google Scholar
• RAHMAN SN, KIM GE, MATHEW AS: Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int. (1994) 45:1731–1738.
   PubMed Web of Science ®Google Scholar
• ALLGREN RL: Update on clinical trials with atrial natriuretic peptide in acute tubular necrosis. Rena] Fail. (1998) 20:691–695.
   PubMed Web of Science ®Google Scholar
• MEYER M, PFARR, SCHURMIER G: Therapeutic use of natriuretic peptide ularitide in acute renal failure. (1999) 21:85–100.
   Google Scholar
• VENKATARAM R, KELLUM JA: The roleof diuretic agents in the management of acute renal failure. Contrib. Nephrol. (2001) 132:158–170.
   Web of Science ®Google Scholar
• KELLUM JA, DECKER J: Use of dopamine in acute renal failure: a meta-analysis. Grit. Care Med. (2001) 29:1526–1531.
   PubMed Web of Science ®Google Scholar
• O'LEARY MJ, BIHARI DJ: Preventing renal failure in the critically ill. Br Med. (2001) 322:1437–1439.
   PubMedGoogle Scholar
• LASSNIGG A, DONNOR E, GRUBHOFER G, PRESTARL E, DRUME W, HIESMAYR M: Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. j Am Soc. Nephro] (2000) 11:97–104.
   PubMed Web of Science ®Google Scholar
• MARIK PE, IGLESIAS J: Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. Am. J. Med. (1999) 107:387–390.
   PubMed Web of Science ®Google Scholar
• CHERTOW GM, SAYEAGH MH, ALLGREN RC, LAZARUS JM: Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure. Am. J. Med. (1996) 101:49–53.
   PubMed Web of Science ®Google Scholar
• GARWOOD S: New pharmacologic options for renal preservation. Anesthesia] N Am. (2000) 18:753–771.
   PubMedGoogle Scholar
• AGMON G, PELEZ D, GREENFIELD Z, ROSEN S, BREZIS M: Nitric oxide and prostanoids protect the outer medulla from radiocontrast toxicity in the rat. Invest. (1994) 94:1012–1075.
   Google Scholar
• BENNETT WM, HENRICH WL, STAFF JS: The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. Am. j Kid. Dis (1996) 285:56–62.
   Google Scholar
• UEDA N, MAYEUX PR, BALIGA R. SHAH SV: Oxident mechanisms in acute renal failure. Am. j Merl (2000) 60–77.
   Google Scholar
• KANAKIRIYA S, NATH KA: Heme oxygenase and acute renal injury. In: Diseases of the Kidney and Urinary Tract. Schrier RW (Ed.), Lippincott Williams & Wilkins, Philadelphia, USA (2001):78–88.
   Google Scholar
• NATH KA, NORBY SM: Reactive oxygen species and acute renal failure. Am. j Med. (2000) 109:665–678.
   PubMed Web of Science ®Google Scholar
• KAZER E, KOREN G: Management of paracetamal overdose: current controversies. Drug Safety (2002) 24:503–511.
   Web of Science ®Google Scholar
• TEPEL M, VANDER GROT M, SCWARZFELD C, LAUFER U, LIERMANN D, ZIDEK W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl. j Merl (2000) 343:180–184.
   PubMed Web of Science ®Google Scholar
• WEINBERG JM: Glutathione and glycinein acute renal failure. Rena] Fail. (1992) 14:311–319.
   PubMed Web of Science ®Google Scholar
• WETZELS JF, YU L, SHANLEY SCHRIER RW: Infusion of glycine does not attenuate in vivo ischemic acute renal failure. J. Lab. Clin. Med. (1993) 121:263–267.
   PubMed Web of Science ®Google Scholar
• GOBE G, XANG XJ, WILLGOSS DA, SCHOCH E, HOGG NA, ENDRE ZH: Relationships between expression of Bc1-2 genes and growth factors in ischemic acute renal failure in the rat. I Am. Soc. Nephro] (2000) 11:454–467.
   PubMed Web of Science ®Google Scholar
• FRANKLIN SC, MOULTON M, SCEARL GA, HAMMERMAN MR, MILLER SB: Insulin-like growth Factor I preserves renal function post-operatively. Am. Physiol Rena] Physio] (1997) 272:F257–259.
   Web of Science ®Google Scholar
• HIRSCHBERG R, KOPPLE J, LYSSETTP et al.: Multicenter clinical treat of recombinant human insulin like growth factor 1 in patients with acute renal failure. Kidney Int. (1997) 55:2423–2432.
   Web of Science ®Google Scholar
• ANDERSON RJ, RAY C, POPOFF M: Evidence for Rho protein regulation of renal tubular cell apoptosis. Kidney Int. (2000) 58:1996–2006.
   PubMed Web of Science ®Google Scholar
• LIANO F, PASCUAL J: Acute renal failurecritical illness and the artificial kidney: can we predict outcome? Blood Purif (1997) 15:346–353.
   PubMed Web of Science ®Google Scholar
• SCHIFFL H, LARRY SM, FISAKER R: Daily hemodialysis and the outcome of acute renal failure. N Engl. j Merl (2002) 346:305–310.
   PubMed Web of Science ®Google Scholar
• STAR RA:Treatment of acute renal failure. Kidney Int. (1998) 54:1817–1831.
   PubMed Web of Science ®Google Scholar
• BONVENTRE JV: Daily hemodialysis - will treatment each day improve the outcome in patients with acute renal failure? N Engl. j Med. (2002) 346:362–364.
   Google Scholar
• MCCARTHY JT: Prognosis of patients with acute renal failure in the intensive care unit: a tale of two eras. Mayo Clin. Proc. (1996) 71:117–126.
   PubMed Web of Science ®Google Scholar
• LIANO F, JUNCO E, PASCUAL J, MADERO R, VERDE E: The spectrum of acute renal failure in the intensivecare unit compared with that seen in other settings. Kidney Int. (1998) 665:16–24.
   Google Scholar